Regulating pre-implantation genetic diagnosis
Subtitle: a comparative and theoretical analysis
By: [edited by] Sheila A.M. McLean, Sarah Elliston
Series: Biomedical law & ethics library
Publisher: Routledge
Published: 2012
Place of publication: Abingdon, Oxon [UK]; New York
Language: eng
Number of pages: 250
ISBN-13: 9780415686440; 9780203096376
Subjects: Preimplantation genetic diagnosis; Human Fertilization in vitro; LAW / Medical Law & Legislation; Law and legislation; Abortion; HEALTH & FITNESS / Pregnancy & Childbirth; Human reproduction; Human embryo; LAW / General; Unborn children (Law); Legal status, laws
Description: "The successful achievement of pregnancies after pre-implantation genetic diagnosis (PGD) was reported in April 1990. The technology is often used for patients who are at substantial risk of conceiving a pregnancy affected by a known genetic disorder, however from this technology other more controversial uses have arisen such as HLA typing to save the life of a sibling, sex selection for social reasons, the prevention of late onset diseases, or to prevent diseases which may be genetically predisposed to developing such as breast cancer. The technology surrounding PGD is constantly developing, giving rise to new and unexpected consequences that create fresh ethical and legal dilemmas. Featuring internationally recognized experts in this field this book critically explores the regulation of PGD and the broader legal and ethical issues. It looks at the regulatory situation in a number of jurisdictions including New Zealand, Asutralia and the UK, but it also explores a number of themes of wide significance including a historical consideration of PGD and its part in the creation of the "genetic embryo" as a political tool, the over-regulation of PGD, the place of the woman in the regulation of PGD and the ethical difficulties in handling this additional unexpected medical information yielded by new technologies"--

"The successful achievement of pregnancies following pre-implantation genetic diagnosis (PGD) was first reported in April 1990. The technology is often used for patients who are at substantial risk of conceiving a pregnancy affected by a known genetic disorder, however from this technology other more controversial uses have arisen such as HLA typing to save the life of a sibling, gender selection for social reasons, the prevention of late onset diseases, or the prevention of diseases which may be genetically predisposed to developing such as breast cancer. The technology surrounding PGD is constantly developing, giving rise to new and unexpected consequences that create fresh ethical and legal dilemmas. Featuring internationally recognized experts in the field, this book critically explores the regulation of PGD and the broader legal and ethical issues associated with it. It looks at the regulatory situation in a number of jurisdictions including New Zealand, Australia and the United Kingdom, but it also explores a number of themes of wide significance including a historical consideration of PGD and its part in the creation of the "genetic embryo" as a political tool, the over regulation of PGD and the ethical difficulties in handling additional unexpected medical information yielded by new technologies. This book will be of particular interest to academics and students of law, medicine and ethics"--